TTF1 and lung adenocarcinoma: For example, pemetrexed‐based chemotherapy, a standard treatment for nonsquamous NSCLC,13, 14, 15 was inferior to pemetrexed‐free regimens in lung adenocarcinoma patients with negative TTF‐1 expression.16